Chronic Kidney Disease Trial, Recruiting (NCT05353660)

Chronic Kidney Disease Trial, Recruiting NCT05353660 Sponsor: Nanfang Hospital, Southern Medical University Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05353660 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older, but younger than 80 years old
Your kidneys are not working well (a blood test shows reduced kidney function below a certain level), OR you have been on regular dialysis for at least 3 months

Who may not be able to join:

You have a muscle or nerve disease, such as muscular dystrophy, ALS (Lou Gehrig's disease), spinal cord injury, stroke, or myasthenia gravis
You have a brain-related degenerative disease, such as Alzheimer's disease, Parkinson's disease, or Huntington's disease
You have an advanced (late-stage) cancer
You have had a serious infection in the past 3 months
You have a serious heart or blood vessel condition affecting your heart or brain
You have moderate to severe swelling (fluid buildup) in your body
You have rheumatoid arthritis, multiple sclerosis, or a severe gout flare-up that makes it hard to move your joints
You are pregnant
The trial doctor has decided for any other reason that this trial is not appropriate for you (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-20-61686217

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05353660

Sponsor: Nanfang Hospital, Southern Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: +86-20-61686217

More information: https://clinicaltrials.gov/study/NCT05353660

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older, but younger than 80 years old
Your kidneys are not working well (a blood test shows reduced kidney function below a certain level), OR you have been on regular dialysis for at least 3 months

Who may not be able to join:

You have a muscle or nerve disease, such as muscular dystrophy, ALS (Lou Gehrig's disease), spinal cord injury, stroke, or myasthenia gravis
You have a brain-related degenerative disease, such as Alzheimer's disease, Parkinson's disease, or Huntington's disease
You have an advanced (late-stage) cancer
You have had a serious infection in the past 3 months
You have a serious heart or blood vessel condition affecting your heart or brain
You have moderate to severe swelling (fluid buildup) in your body
You have rheumatoid arthritis, multiple sclerosis, or a severe gout flare-up that makes it hard to move your joints
You are pregnant
The trial doctor has decided for any other reason that this trial is not appropriate for you (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nanfang Hospital, Southern Medical University

Registry

ClinicalTrials.gov

Start date

11 April 2022

Est. completion

31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

sarcopenia; The progression of chronic kidney diseases in CKD patients; All-cause mortality in maintenance hemodialysis patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov